Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New therapies for hepatitis C].

Lucía Gil-Guerrero1, Pablo Sarobe, Jesús Prieto

  • 1Clínica Universitaria y Centro de Investigación Médica Aplicada, Universidad de Navarra, Pamplona, Navarra, España. lugilgue@unav.es

Medicina Clinica
|July 11, 2006
PubMed
Summary

Hepatitis C virus (HCV) infection poses a significant global health challenge due to its prevalence and treatment resistance. New therapies target viral replication, immune evasion, and infection blockade for improved outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiotherapy and AAV-based immunotherapy: A new alliance for cancer treatment.

Molecular therapy. Oncology·2026
Same author

Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.

Cell reports. Medicine·2026
Same author

Radiotherapy synergizes with an inducible AAV-based immunotherapy platform to program local and systemic antitumor immunity.

Cancer cell·2026
Same author

Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy.

Oncoimmunology·2026
Same author

Screening for Mutations Causing ACOX2 Deficiency-associated Hypertransaminasemia in Patients with Cryptogenic Liver Injury.

Journal of clinical and translational hepatology·2025
Same author

MEF2D-expressing cancer precursors reprogram tissue-resident macrophages to support liver tumorigenesis.

Nature cancer·2025

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Context:

  • Hepatitis C virus (HCV) infection is a major global health concern.
  • Existing therapies like pegylated interferon and ribavirin face high resistance rates.
  • HCV employs sophisticated mechanisms to evade host immune responses and interferon treatments.

Purpose:

  • To explore novel therapeutic strategies for Hepatitis C virus (HCV) infection.
  • To address the limitations of current antiviral treatments.
  • To leverage a deeper understanding of viral structure, function, and evasion tactics.

Summary:

  • New therapeutic approaches for HCV focus on inhibiting viral replication by targeting proteases and replicases.
  • Alternative interferon types with enhanced antiviral potency are being investigated.
  • Strategies include inducing specific anti-HCV immune responses via immunomodulators or therapeutic vaccines.
  • Blocking new cell infections with neutralizing antibodies and inducing an antiviral liver state through gene transfer are also explored.

Impact:

  • Development of more effective treatments for Hepatitis C virus (HCV).
  • Overcoming antiviral resistance in HCV infections.
  • Reducing the global burden of Hepatitis C virus (HCV).

Related Experiment Videos